World’s first lung cancer vaccine trial launched

I show You how To Make Huge Profits In A Short Time With Cryptos!

ANKARA — Physicians have launched the world’s first mRNA lung cancer vaccine trial across seven countries, including Türkiye, in a groundbreaking effort that could revolutionize cancer treatment, according to press reports on Friday.

The vaccine, known as BNT116 and developed by BioNTech, is designed to target non-small cell lung cancer (NSCLC), the most common type of lung cancer.

Be the first to comment

Leave a Reply

Your email address will not be published.


*